Article
Targeted and genome-wide sequencing reveal single nucleotide variations impacting specificity of Cas9 in human stem cells.
Nature communications - 26 Nov 2014
Yang Luhan, Grishin Dennis, Wang Gang, Aach John, Zhang Cheng-Zhong, Chari Raj, Homsy Jason, Cai Xuyu, Zhao Yue, Fan Jian-Bing, Seidman Christine, Seidman Jonathan, Pu William, Church George
Abstract excerpt
CRISPR/Cas9 has demonstrated a high-efficiency in site-specific gene targeting. However, potential off-target effects of the Cas9 nuclease represent a major safety concern for any therapeutic application. Here, we knock out the Tafazzin gene by CRISPR/Cas9 in human-induced pluripotent stem cells with 54% efficiency. We combine whole-genome sequencing and deep-targeted sequencing to characterise the off-target...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
